MedPage Today) -- ORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative...
Copyright © 2023 cape-breton.com. Toady's News. All Rights Reserved